Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
MacroGenics Inc.

Start price
Target price
Perf. (%)
€22.94
08.07.21
-
08.07.22
-85.09%
08.07.22

buy
Staar Surgical Co.

Start price
Target price
Perf. (%)
€120.00
08.07.21
-
08.07.22
-35.90%
08.07.22

buy
MicroVision Inc

Start price
Target price
Perf. (%)
€12.65
08.07.21
-
08.07.22
-62.55%
08.07.22

buy
Valneva SE

Start price
Target price
Perf. (%)
€11.85
08.07.21
-
08.07.22
-11.18%
08.07.22

buy
Stratec SE

Start price
Target price
Perf. (%)
€117.40
08.07.21
-
08.07.22
-19.51%
08.07.22

buy
Athersys Inc.

Start price
Target price
Perf. (%)
€23.38
30.11.21
€25.00
30.11.22
-71.89%
07.07.22

Could be worthwhile Investment >10% per year
Innovative
Few uniques
buy
Apellis Pharmaceuticals

Start price
Target price
Perf. (%)
€37.80
13.11.21
€50.00
31.12.23
11.71%
29.06.22

Could be very worthwhile Investment >20% year
buy
Agile Therapeutics Inc.

Start price
Target price
Perf. (%)
€79.50
27.06.22
€100.00
27.06.23
40.88%
28.06.22

Could be worthwhile Investment >10% per year
Capable Management
Very good company culture
Little innovation
buy
Kezar Life Sciences

Start price
Target price
Perf. (%)
€10.20
16.11.21
€11.00
31.12.24
0.98%
28.06.22

Could be very worthwhile Investment >20% year
buy
Otonomy Inc.

Start price
Target price
Perf. (%)
€1.67
25.10.21
€3.00
31.12.23
21.68%
28.06.22

Could be very worthwhile Investment >20% year
buy
Cytokinetics Inc.

Start price
Target price
Perf. (%)
€28.20
30.08.21
€50.00
31.12.23
63.83%
28.06.22

Could be very worthwhile Investment >20% year
buy
Syros Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€46.00
26.06.21
-
26.06.22
-81.82%
27.06.22

Could be very worthwhile Investment >20% year
buy
Forte Biosciences Inc.

Start price
Target price
Perf. (%)
€1.10
13.06.22
€1.00
13.06.23
7.81%
25.06.22

Capable Management
Could be very worthwhile Investment >20% year
Few uniques
buy
Rigel Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€1.30
01.04.20
€4.88
24.10.24
-47.02%
13.06.22

buy
Novan Inc

Start price
Target price
Perf. (%)
€12.12
12.06.21
-
12.06.22
-81.58%
13.06.22

Could be worthwhile Investment >10% per year
buy
MacroGenics Inc.

Start price
Target price
Perf. (%)
€3.28
29.05.22
-
29.05.23
-25.00%
12.06.22

Risky Investment
buy
CareCloud Inc.

Start price
Target price
Perf. (%)
€7.30
12.06.21
-
12.06.22
-55.62%
12.06.22

buy
Novavax Inc.

Start price
Target price
Perf. (%)
€42.57
03.06.22
-
03.06.23
-9.55%
11.06.22

Risky Investment
buy
Minerva Neurosciences Inc.

Start price
Target price
Perf. (%)
€4.81
14.03.22
€6.40
14.03.23
-33.68%
11.06.22

Standard Investments for future growth
Higher EBIT margin than peer group
Very low/no dividend yield expected
ROE lower than 10% per year
buy
Drägerwerk AG & Co. KGaA VZO

Start price
Target price
Perf. (%)
€49.15
01.06.22
-
01.06.23
-2.34%
11.06.22

Market Leader or Top 3
Well known brand
Very Future proof/growth oriented business model
Revenue growth > 30% per year expected
buy
Forte Biosciences Inc.

Start price
Target price
Perf. (%)
€1.19
30.05.22
-
30.05.23
-7.79%
11.06.22

Capable Management
Could be very worthwhile Investment >20% year
Few uniques
buy
Fate Therapeutics Inc.

Start price
Target price
Perf. (%)
€22.29
29.05.22
-
29.05.23
-0.67%
09.06.22

Could be very worthwhile Investment >20% year
buy
Affimed N.V.

Start price
Target price
Perf. (%)
€4.75
11.04.22
-
11.04.23
-41.07%
08.06.22

Could be worthwhile Investment >10% per year
buy
Novavax Inc.

Start price
Target price
Perf. (%)
€114.10
07.01.22
€130.00
07.01.23
-63.63%
05.06.22

Could be worthwhile Investment >10% per year
buy
Sangamo Therapeutics Inc.

Start price
Target price
Perf. (%)
€8.74
31.05.21
€15.00
31.05.22
-60.61%
01.06.22

Fair valuation
Strong uniques
Leading role in innovation
Bad rating